RTI-HS Home
› Our Services
› Biometrics
› Exploratory Data Analysis
Exploratory Data Analysis
We can help you design exploratory analyses, analyze data, provide guidance on next steps, assist in reporting the results to regulators, and prepare manuscripts for peer-reviewed journals. We have extensive experience in exploring post-hoc requests from clinical trial data and other sources. Our SOP on exploratory data analysis ensures that our work is well-organized and target-driven.
Before or just after product launch, you may want to explore outcomes for subgroups within the trial. Specifically in cancer trials, new information may become available during the conduct of a trial that leads to specific subpopulations of interest for your drug. Post-hoc analyses of clinical trial data are often delayed while preparation of an NDA takes priority. You may have already shown efficacy in the subgroup and it can be beneficial to publish other measures of clinical benefit in that subgroup, such as sustained response or improved HRQOL. We can also help you evaluate long-term follow-up data from your clinical trials.
We often provide additional evidence as inputs for health technology assessments (HTAs), using such techniques as parametric survival modeling.
We can quickly assemble a team from other areas of expertise at RTI-HS, including health economics, outcomes research, and epidemiology to evaluate existing data for new value messages.
Our Expertise
